Moreover, in the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) guideline, ACE inhibitors are stated as the commonly recommended antihypertensive drugs in comorbid hypertension and renal impairment; ARBs are recommended when ACE inhibitors are not tolerated or contraindicated [36]. The gene discussed is ACE; the disease is hypertensive disorder.